Head-to-head comparison
NativeMed vs Peter MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299) and compounded tirzepatide at promotional $183/mo.
$149/mo (promo rate) sema · $183/mo (promo rate) tirz · Verified July 2026
Marked down on: Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Verified August 2026
Marked down on: Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly
Peter MD takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for NativeMed. NativeMed still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
NativeMed
62/100
C
Peter MD
77/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | NativeMed | Peter MD |
|---|---|---|
| Semaglutide | $149/mopromo rate$149/mo (promotional rate, compounded) | $149/mofirst month only$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) |
| Tirzepatide | $183/mopromo rate$183/mo (promotional rate, compounded) | $249/moquarterly prepay$249/mo (60mg, billed quarterly; $149 first month) |
| Coverage | Not listed on NativeMed's site (checked July 2026) | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Sub-$200 promotional compounded GLP-1 pricing. | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. |
| Desk Score | 62/100C | 77/100C+ |
The verdict
Desk pick — Peter MDPeter MD takes this head-to-head with the higher Desk Score, 77/100 (C+) against 62/100 (C) for NativeMed. NativeMed still holds its ground where its strengths line up with yours.
Choose NativeMed if…
Sub-$200 promotional compounded GLP-1 pricing.
$149/mo (promo rate) sema · $183/mo (promo rate) tirz
FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: NativeMed · Peter MD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs NativeMed
- CoreAge Rx vs Peter MD
- NativeMed vs Ondra Health
- Ondra Health vs Peter MD
- NativeMed vs Tyde Wellness
- Peter MD vs Tyde Wellness
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.